Inverseon’s Founder and SAB Member Published in PNAS

SAN FRANCISCO, Feb. 19, 2009 — Inverseon, Inc. (http://www.inverseon.com) announces the publication in the February 17, 2009 issue of the Proceedings of the National Academy of Sciences (PNAS) entitled, “Beta2-adrenoceptor signaling is required for the development of an asthma phen…

Inverseon’s Asthma Therapy Receives Notice of Allowance; Clinical Trial Highlighted in Lancet

SAN FRANCISCO, Jan. 14, 2009 — Inverseon, Inc. (http://www.inverseon.com) announces the receipt of a notice of allowance from the United States Patent Office covering its oral product INV102 for asthma. Additionally, a comment highlighting Inverseon’s clinical asthma study was publ…